BL Pharmtech Agrees to Sell 13.96% Stake in Kwangdong Healthbio

PUBT · 1d ago
BL Pharmtech Agrees to Sell 13.96% Stake in Kwangdong Healthbio
  • BL Pharmtech signed a November 5, 2026, agreement to sell its 1,770,958 Kwangdong Healthbio shares, representing a 13.96% stake.
  • Full payment and share transfer are scheduled for January 4, 2027. Its holding remained unchanged at the disclosure date.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kwangdong Healthbio Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261105000538), on November 05, 2026, and is solely responsible for the information contained therein.